Skip to main content
Premium Trial:

Request an Annual Quote

House Subcommittee Bill Proposes 7 Percent NIH Budget Increase

NEW YORK — The US House of Representatives Appropriations Committee on Tuesday proposed a fiscal year 2020 spending package that includes a $2.6 billion boost in funding for the National Institutes of Health, as well as budget increases for the US Centers for Disease Control and Prevention and the US Food and Drug Administration.

The legislation would provide the NIH with $41.7 billion for the upcoming fiscal year, a nearly 7 percent increase over the agency's current budget. The bill would specifically allocate $500 million for the All of Us precision medicine program, $500 million for the BRAIN Initiative, $195 million for the Cancer Moonshot research initiative, and $50 million for the Childhood Cancer Data Initiative. 

The CDC, meanwhile, will receive an additional $636 million for a total of $8 billion in fiscal year 2020 funding under the legislation, with the FDA receiving a $91 million increase in discretionary funding to $3.16 billion. 

The full House and US Senate are expected to pass the House appropriations package, sending the legislation to the White House for President Donald Trump's signature, before the federal government's funding runs out on Friday at midnight.

The Scan

For STEM Students to Stay

New policy changes will make it easier for international STEM students to stay in the US after graduation, the Wall Street Journal reports.

To Inform or Not, To Know or Not

The New York Times writes that some genetic biobanks may re-contact donors if they spot something troublesome, but it notes that not all donors want that information.

Rapid Test Studies

Researchers are examining why rapid tests may be less effective at detecting the Omicron variant and how to improve them, NPR says.

PLOS Papers on SARS-CoV-2 Diversity in Delaware, Metastatic Breast Cancer, Adiposity GWAS

In PLOS this week: genomic analysis of SARS-CoV-2 isolates from Delaware, gene expression and protein-protein interaction patterns in metastatic breast cancer, and more.